Kamis, 21 Juni 2012

Slowing Aging By Blocking A Protein

Slowing Aging By Blocking A Protein

Editor's Choice
Main Category: Seniors / Aging
Also Included In: Genetics
Article Date: 21 Jun 2012 - 11:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions   <!-- rate icon rate article


Patient / Public:not yet rated

Healthcare Prof:not yet rated


Researchers at the University of Pittsburgh School of Medicine have successfully slowed down the aging process in mice by blocking a protein that regulates the activity of certain genes. The study is published in the Journal of Clinical Investigation.

The teams findings could lead to the development of new drugs that prevent cellular damage from aging, cancer, and diseases caused by abnormal DNA repair activity.

Senior author Paul Robbins, Ph.D., a professor in the Department of Microbiology and Molecular Genetics at Pitt's School of Medicine, explained that accumulated cellular damage, including DNA damage, is believed to be responsible for aging. However, researchers still do not understand the biological mechanisms that power the aging process in response to damage.

Robbins and his colleagues examined a protein called NF-Kappa B. This protein is involved in switching on and off certain gene activity in response to stress, inflammation, and cellular damage.

Robbins explained:

"Other studies have shown that NF-kappa B activity is elevated in aging tissues. We examined whether this held true for mice with progeria, a disease of accelerated aging, and what would happen is we blocked NF-kappa B activation."

The team discovered that old and progeroid mice had a higher ratio of cells that contained activated NF-kappa B than healthy mice. According to the researchers, age-related activation of NK-kappa B occurs in some cells but not all.

The team found that blocking NF-kappa B's activation with chemicals or slightly changing its expression delayed the onset and reduced the severity of age-related changes in tissues, including kidney, muscle, liver and the nervous system. Furthermore, they discovered that blocking NF-kappa B reduced free radical-induced oxidative damage.

Robbins explained:

"It's possible that as we age, NF-kappa B becomes activated by accumulation of cellular damage, and that in turn increases the production of free radicals, resulting in more cell damage. An agent that blocks this protein could be used to slow down aging and also to treat certain cancers and diseases such as xeroderma pigmentosum, which are characterized by altered DNA repair activity."

Written By Grace Rattue
Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today

"NF-κB inhibition delays DNA damageâ€"induced senescence and aging in mice"
Jeremy S. Tilstra, Andria R. Robinson, Jin Wang, Siobhán Q. Gregg, Cheryl L. Clauson, Daniel P. Reay, Luigi A. Nasto, Claudette M. St Croix, Arvydas Usas, Nam Vo, Johnny Huard, Paula R. Clemens, Donna B. Stolz, Denis C. Guttridge, Simon C. Watkins, George A. Garinis, Yinsheng Wang, Laura J. Niedernhofer, and Paul D. Robbins
JCI, June 2012, doi: 10.1172/JCI45785. Please use one of the following formats to cite this article in your essay, paper or report:

MLA


APA

Please note: If no author information is provided, the source is cited instead.



Add Your Opinion On This Article

'Slowing Aging By Blocking A Protein'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



MediLexicon International Ltd Logo

Privacy Policy | Terms and Conditions

MediLexicon International Ltd
Bexhill-on-Sea, United Kingdom
MediLexicon International Ltd © 2004-2012 All rights reserved.
MNT (logo) is the registered EU trade mark of MediLexicon Int. Limited.

Everyday Health Network back to top | home | privacy policy

MediLexicon International Ltd Logo MediLexicon International Ltd
Bexhill-on-Sea, United Kingdom
MediLexicon International Ltd © 2004-2012 All rights reserved.
MNT (logo) is the registered EU trade mark of MediLexicon Int. Limited.

Tidak ada komentar:

Posting Komentar